|
Home | Issues | eMJA shop | My account | Classifieds | Contact | More... | Topics | Search |
→ Contents list for this issue
→ More articles on Sexual health
→ More articles on General medicine
→ Search PubMed for related articles
Click to Login
Hide the Login Box
→ Register for free access if you don't have an account
Introduction
—Neurobiogenesis of ejaculation
—Management of the patient
—Medical history and medications
—Physical examination
—Investigations
—Management plan
—Behavioural techniques
—Measures that reduce penile sensation
—Psychological counselling
—Pharmacological treatments
—Tricyclic antidepressants
—Selective serotonin reuptake inhibitors
—Phosphodiesterase inhibitors
—Daily versus on-demand therapy
—Combination therapy
—Treatment of secondary PE
—Conclusion
—Acknowledgements
—Competing interests
—Author details
—References
Premature ejaculation (PE) is ejaculation occurring without control, on or shortly after vaginal penetration and before the subject wishes it, causing marked distress or interpersonal difficulties.
PE is the most common male sexual complaint. Primary (lifelong) PE has a physiological basis.
Therapy should involve the man and his partner. The primary aims of therapy are for the man to regain a sense of control over his ejaculation time and for him and his partner to feel satisfaction with sexual intercourse.
The most effective therapies for primary PE are certain selective serotonin reuptake inhibitors, given on a daily basis or “on demand” before sexual activity. Topical anaesthetics have also been shown to be effective.
The most common cause of secondary PE is declining erectile function. The approach to treating secondary PE is to treat the underlying condition.
Login or register for free access to the full article
|
|
Home | Issues | eMJA shop | My account | Classifieds | More... | Contact | Topics | Search |
©The Medical Journal of Australia 2008 www.mja.com.au PRINT ISSN: 0025-729X ONLINE ISSN: 1326-5377